HCV GT2
Showing 1 - 25 of 4,779
Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)
Not yet recruiting
- Hepatitis C
- Cirrhosis
- Sofosbuvir/Velpatasvir + Ribavirin
- Sofosbuvir/Velpatasvir/Voxilaprevir
- (no location specified)
Jul 20, 2022
Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)
Recruiting
- Chronic Hepatitis C Virus
- +4 more
-
Bucuresti, BUC, RomaniaAtea Study Site
Jun 15, 2023
Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)
Recruiting
- Hepatitis C, Chronic
- P1101 + Ribavirin
-
Chiayi City, Taiwan
- +7 more
Jun 30, 2022
Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual
Recruiting
- Hepatitis C Virus Infection, Response to Therapy of
- Test and treat plus peer mentors
- Usual care
-
Birmingham, Alabama
- +3 more
Dec 9, 2022
Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)
Not yet recruiting
- Liver Cirrhosis
-
Bunkyo-Ku, Tokyo, JapanTokyo Metropolitan Komagome Hospital
Nov 29, 2023
Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))
NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)
Not yet recruiting
- NSCLC Stage IV
- +4 more
- Nivolumab and Ipilimumab
-
Verona, Veneto/Verona, ItalyCentro Ricerche Cliniche
Oct 26, 2022
HIV, HCV Infection, Syphilis Infection Trial in St. John's (Choice of STBBI test(s))
Not yet recruiting
- HIV Infections
- +2 more
- Choice of STBBI test(s)
-
St. John's, Newfoundland & Labrador, CanadaMemorial University of Newfoundland
Sep 6, 2022
HCV, Substance Use Disorders Trial in France, Martinique (Hybrid effectiveness-implementation study type 2)
Not yet recruiting
- HCV
- Substance Use Disorders
- Hybrid effectiveness-implementation study type 2
-
Lyon, Auvergne-Rhône-Alpes, France
- +3 more
Mar 20, 2023
HCV Infection Trial in Hong Kong (SOF+DCV+CDI-31244, SOF+DCV+CDI-31244+ASV)
Withdrawn
- HCV Infection
-
Hong Kong, Hong Kong SAR, Hong KongHumanity & Health Research Centre
May 5, 2020
SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients
Recruiting
- Hepatitis C
- Epclusa (sofosbuvir and velpatasvir)
-
Guangzhou, Guangdong, ChinaDeparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021
Eliminating HCV Infection Among PWUD
Recruiting
- Hepatitis C, Chronic
- Drug Use
-
Vancouver, British Columbia, CanadaVancouver Infectious Diseases Centre
Jul 22, 2022
HCV Trial in United States (Prophylaxis (P2W), Transmit and Treat (T&T))
Not yet recruiting
- HCV
- Prophylaxis (P2W)
- Transmit and Treat (T&T)
-
New Orleans, Louisiana
- +5 more
Dec 6, 2022
Obesity, Type 2 Diabetes Trial (MagGJ System)
Not yet recruiting
- Obesity
- Type 2 Diabetes
- MagGJ System
- (no location specified)
Oct 5, 2023
Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)
Not yet recruiting
- Hiv
- BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
-
Amsterdam, NetherlandsThe Amsterdam University Medical Centers
Aug 2, 2023
Advanced Solid Tumor Trial in Brussels (GTAEXS617)
Recruiting
- Advanced Solid Tumor
-
Brussels, BelgiumClinique Universitaires Saint-Luc
Aug 8, 2023
Type 2 Diabetes, Obesity Trial in Tbilisi (MAGNET System, DI Bio-fragmentable)
Recruiting
- Type 2 Diabetes
- Obesity
- MAGNET System, DI Bio-fragmentable
-
Tbilisi, GeorgiaInnova Medical Center
Jan 11, 2023
Treatment of Femur Fractures With the Femoral Nail GT
Recruiting
- Femoral Fracture
- Femoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing System
-
Sartell, Minnesota
- +3 more
Jan 17, 2022
Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)
Completed
- Chronic Hepatitis C
- Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
- (no location specified)
Jan 15, 2021
Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)
Completed
- Hepatitis C Infection
- Grazoprevir + Elbasvir
- Ribavirin
- (no location specified)
Jan 15, 2021
Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)
Completed
- Chronic HCV Infection
- Elbasvir/Grazoprevir Fixed Dose Combination
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Sep 9, 2020
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- ABT-493/ABT-530
- +2 more
- (no location specified)
Jul 14, 2021
Hepatitis C, Opioid Use Disorder, IV Drug Usage Trial in Keene, Brattleboro (Mobile Tele-HCV Care, Enhanced Usual Care)
Recruiting
- Hepatitis C
- +2 more
- Mobile Tele-HCV Care
- Enhanced Usual Care
-
Keene, New Hampshire
- +1 more
Jul 18, 2022